{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:24:29Z","timestamp":1789835069840,"version":"4.0.1"},"reference-count":52,"publisher":"European Respiratory Society (ERS)","issue":"6","funder":[{"DOI":"10.13039\/100015153","name":"\u201cAir liquide\" foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015153","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["\" Investissements d\u2019avenir\u201d program (ANR-15-ID"],"award-info":[{"award-number":["\" Investissements d\u2019avenir\u201d program (ANR-15-ID"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mutualia"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007772","name":"Agir pour les Maladies Chroniques","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2017,2,23]]},"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is independently linked to cardiometabolic morbidity and mortality. Low-grade inflammation, oxidative stress and ectopic fat, common features of chronic obstructive pulmonary disease (COPD), might contribute to the development of NAFLD.<\/jats:p><jats:p>We aimed to investigate the prevalence of NAFLD and to evaluate the relationship between various types of liver damage and COPD severity, comorbidities and circulating inflammatory cytokines. Validated noninvasive tests (FibroMax: SteatoTest, NashTest and FibroTest) were used to assess steatosis, nonalcoholic steatohepatitis (NASH) and liver fibrosis. Patients underwent an objective assessment of COPD comorbidities, including sleep studies. Biological parameters included a complete lipid profile and inflammatory markers.<\/jats:p><jats:p>In COPD patients the prevalence of steatosis, NASH and fibrosis were 41.4%, 36.9% and 61.3%, respectively. In multivariate analysis, SteatoTest and FibroTest were significantly associated with sex, body mass index (BMI), untreated sleep apnoea and insulin resistance, and, in addition, COPD Global Initiative for Chronic Obstructive Lung Disease stage for SteatoTest. Patients with steatosis had higher tumour necrosis factor-\u03b1 levels and those with NASH or a combination of liver damage types had raised leptin levels after adjustment for age, sex and BMI.<\/jats:p><jats:p>We concluded that NAFLD is highly prevalent in COPD and might contribute to cardiometabolic comorbidities.<\/jats:p>","DOI":"10.1183\/13993003.01923-2016","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:10:19Z","timestamp":1496967019000},"page":"1601923","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease"],"prefix":"10.1183","volume":"49","author":[{"given":"Damien","family":"Viglino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Jullian-Desayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Minoves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Aron-Wisnewsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Zarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Tamisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Joyeux-Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"P\u00e9pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"2024101903563309000_49.6.1601923.1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762"},{"key":"2024101903563309000_49.6.1601923.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2024101903563309000_49.6.1601923.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.05.044"},{"key":"2024101903563309000_49.6.1601923.4","doi-asserted-by":"crossref","unstructured":"Bedossa P , Tordjman J , Aron-Wisnewsky J , et\u00a0al. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity. Gut 2016 [In press DOI: 10.1136\/gutjnl-2016-312238].","DOI":"10.1136\/gutjnl-2016-312238"},{"key":"2024101903563309000_49.6.1601923.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25889"},{"key":"2024101903563309000_49.6.1601923.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.5370"},{"key":"2024101903563309000_49.6.1601923.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"2024101903563309000_49.6.1601923.8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1204265"},{"key":"2024101903563309000_49.6.1601923.9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.metabol.2016.05.004","article-title":"Nonalcoholic fatty liver disease and obstructive sleep apnea","volume":"65","author":"Aron-Wisnewsky","year":"2016","journal-title":"Metabolism"},{"key":"2024101903563309000_49.6.1601923.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.09.020"},{"key":"2024101903563309000_49.6.1601923.11","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features: insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol Res"},{"key":"2024101903563309000_49.6.1601923.12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"2024101903563309000_49.6.1601923.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.013"},{"key":"2024101903563309000_49.6.1601923.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201201-0034OC"},{"key":"2024101903563309000_49.6.1601923.15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/15412555.2016.1140732","article-title":"The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: a systematic review","volume":"13","author":"Cebron Lipovec","year":"2016","journal-title":"COPD"},{"key":"2024101903563309000_49.6.1601923.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201210-1953ED"},{"key":"2024101903563309000_49.6.1601923.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0455PP"},{"key":"2024101903563309000_49.6.1601923.18","doi-asserted-by":"publisher","DOI":"10.1097\/00008483-200507000-00010"},{"key":"2024101903563309000_49.6.1601923.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00148014"},{"key":"2024101903563309000_49.6.1601923.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00114307"},{"key":"2024101903563309000_49.6.1601923.21","doi-asserted-by":"crossref","first-page":"585989","DOI":"10.1155\/2010\/585989","article-title":"Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives","volume":"2010","author":"Tkacova","year":"2010","journal-title":"Mediators Inflamm"},{"key":"2024101903563309000_49.6.1601923.22","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00241-6"},{"key":"2024101903563309000_49.6.1601923.23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1164\/rccm.201412-2296RR","article-title":"New insights in chronic obstructive pulmonary disease and comorbidity","volume":"191","author":"Cleutjens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101903563309000_49.6.1601923.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201208-1441OE"},{"key":"2024101903563309000_49.6.1601923.25","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.2169\/internalmedicine.49.3948","article-title":"High COPD prevalence in patients with liver disease","volume":"49","author":"Minakata","year":"2010","journal-title":"Intern Med"},{"key":"2024101903563309000_49.6.1601923.26","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0133"},{"key":"2024101903563309000_49.6.1601923.27","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0938"},{"key":"2024101903563309000_49.6.1601923.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.04.022"},{"key":"2024101903563309000_49.6.1601923.29","first-page":"187","article-title":"Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience","volume":"17","author":"Munteanu","year":"2008","journal-title":"J Gastrointest Liver Dis"},{"key":"2024101903563309000_49.6.1601923.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2011.01.002"},{"key":"2024101903563309000_49.6.1601923.31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/17474124.2015.1007955","article-title":"Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications","volume":"9","author":"Ballestri","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2024101903563309000_49.6.1601923.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.01.021"},{"key":"2024101903563309000_49.6.1601923.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2015.08.004"},{"key":"2024101903563309000_49.6.1601923.34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/14737159.7.5.481","article-title":"FibroMAX: towards a new universal biomarker of liver disease?","volume":"7","author":"Morra","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"key":"2024101903563309000_49.6.1601923.35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240201"},{"key":"2024101903563309000_49.6.1601923.36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-2600(16)00097-7","article-title":"Management of chronic obstructive pulmonary disease beyond the lungs","volume":"4","author":"Vanfleteren","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024101903563309000_49.6.1601923.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201209-1665OC"},{"key":"2024101903563309000_49.6.1601923.38","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201403-125OC"},{"key":"2024101903563309000_49.6.1601923.39","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00171614"},{"key":"2024101903563309000_49.6.1601923.40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.084"},{"issue":"Suppl. 4","key":"2024101903563309000_49.6.1601923.41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of NAFLD\/NASH","volume":"28","author":"Hashimoto","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"2024101903563309000_49.6.1601923.42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.rmed.2014.04.001","article-title":"A possible link between increased metabolic activity of fat tissue and aortic wall inflammation in subjects with COPD. A retrospective 18F-FDG-PET\/CT pilot study","volume":"108","author":"Vanfleteren","year":"2014","journal-title":"Respir Med"},{"key":"2024101903563309000_49.6.1601923.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2010.04.007"},{"key":"2024101903563309000_49.6.1601923.44","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.112.040774"},{"key":"2024101903563309000_49.6.1601923.45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.metabol.2015.11.006","article-title":"Adipokines in nonalcoholic fatty liver disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"key":"2024101903563309000_49.6.1601923.46","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.metabol.2015.12.009","article-title":"Nonalcoholic fatty future disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"key":"2024101903563309000_49.6.1601923.47","doi-asserted-by":"publisher","DOI":"10.1159\/000282083"},{"key":"2024101903563309000_49.6.1601923.48","doi-asserted-by":"crossref","first-page":"31542","DOI":"10.1038\/srep31542","article-title":"Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice","volume":"6","author":"Mulder","year":"2016","journal-title":"Sci Rep"},{"key":"2024101903563309000_49.6.1601923.49","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M034272"},{"key":"2024101903563309000_49.6.1601923.50","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1053\/j.gastro.2016.03.004","article-title":"Perspectives on treatment for nonalcoholic steatohepatitis","volume":"150","author":"Lassailly","year":"2016","journal-title":"Gastroenterology"},{"key":"2024101903563309000_49.6.1601923.51","first-page":"16682","article-title":"Risk factors of nosocomial bloodstream infections in surgical intensive care unit","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2024101903563309000_49.6.1601923.52","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jamainternmed.2016.3221","article-title":"Moderate exercise for nonalcoholic fatty liver disease","volume":"176","author":"Prenner","year":"2016","journal-title":"JAMA Intern Med"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01923-2016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:41:40Z","timestamp":1740379300000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01923-2016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,8]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1183\/13993003.01923-2016"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01923-2016","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}